GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Berry Genomics Co Ltd (SZSE:000710) » Definitions » Gross-Profit-to-Asset %

Berry Genomics Co (SZSE:000710) Gross-Profit-to-Asset % : 17.94% (As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Berry Genomics Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ¥431 Mil. Berry Genomics Co's average Total Assets over the quarter that ended in Mar. 2025 was ¥2,403 Mil. Therefore, Berry Genomics Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 17.94%.


Berry Genomics Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Berry Genomics Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co Gross-Profit-to-Asset % Chart

Berry Genomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.56 18.74 17.40 17.33 19.71

Berry Genomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.62 19.16 18.87 14.45 17.94

Competitive Comparison of Berry Genomics Co's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Berry Genomics Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Berry Genomics Co's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Berry Genomics Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Berry Genomics Co's Gross-Profit-to-Asset % falls into.


;
;

Berry Genomics Co Gross-Profit-to-Asset % Calculation

Berry Genomics Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=505.256/( (2741.165+2384.724)/ 2 )
=505.256/2562.9445
=19.71 %

Berry Genomics Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=431.004/( (2384.724+2421.244)/ 2 )
=431.004/2402.984
=17.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Berry Genomics Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Berry Genomics Co Business Description

Traded in Other Exchanges
N/A
Address
Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN
Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.
Executives
Gao Yang Directors, executives
Hou Ying Directors, executives
Wang Yu Jing Supervisors
Wang Dong Directors, executives
Zhou Dai Xing Directors, executives
Ou Yang Xiang Yu Supervisors
Li Guang Chao Independent director
Gu Zhong Guo Directors, executives
Wen Wu Director
Ding Xian Xing Supervisors

Berry Genomics Co Headlines

No Headlines